書籍詳細

特別寄稿

P.6 掲載の参考文献

• 1) Palmer RMJ, Ashtoll DS and Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988.

• 2) Ignarro LJ: Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41: 485-490, 1991.
  pubmed

• 3) Kosaka H, Harada N and Watanabe M: Detection of nitric oxide production in lipopolysaccharide-treated rats by ESR using carbon monooxide hemoglobin. Biochem. Biophys. Res. Commun. 184: 1119-1124, 1992.

• 4) Akaike T, Yoshida M, Miyamoto Y, et al: Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction. Biochemistry 32: 827-832, 1993.
  pubmed

• 5) Yoshikawa T, Murakami M, Seto O, et al: Effects of superoxide dismutase and catalase on endotoxin shock. J. Clin. Biochem. Nutr. 1: 165-170, 1986. 1: 165-170, 1986.

• 6) Hutcheson IR, Whittle BJR and Boughton-Smith NK: Role of nitric oxide in maintaining vascular integrity in endotoxin-in-duced acute intestinal damage in the rat. Br. J. pharmacol. 101: 815-820, 1990.

• 7) Boughton-Smith NK, Hutcheson IR, Deakin AM, et al: Protective effect of S-nitroso-N-acetyl-penicilamine in endotoxin-induced acute intestinal damage in the rat. Eur. J. Pharmacol. 191: 485-488, 1990.

• 8) Takahashi S: Role of nitric oxide in acute intestinal damage induced by endotoxin in rats. J. Kyoto Pref. Univ. Med. 102: 107-128, 1993. fed. 102: 107-128, 1993.

• 9) Petros A, Bennett D and Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557-1558, 1991.
  pubmed

• 10) Vallance P and Moncada S: Hyperdyllamic circulatioll in cirrhosis; a role for nitric oxide? Lancet 337: 776-778, 1991.
  pubmed

• 11) Caplan MS, Hedlund E, Hill N, et al: The role of endogellous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. Gastroenterology 106: 346-352, 1994.
  pubmed

• 12) Roediger WEW, Lawson MJ and Nance SH: Detectable colonic nitrite levels in inflammatory bowel diseases-mucosal or bacterial malfunction? Digestion 35: 199-204, 1986.
  pubmed

• 13) Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, et al: Amelioration of chrotlic ileitis by nitric oxide synthase inhibition. J. Pharmacol. Exp Therap. 264: 11-16, 1993.

• 14) Billiar TR, Curran RD, Stuehr DJ, et al: An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J. Exp. Med. 169: 1467-1472. 1989.

• 15) Oshita M, Takei Y, Kawano S, et al: Role of endothelin-1 and nitric oxide in the mechanism for ethanol. induced vasoconstriction in rat liver. J. Clin. Invest. 91: 1337-1342, 1993.

• 16) Oshita M, Sato N, Yoshihara H, et al: Ethanol-induced vasocollstriction causes focal hepatocellular injury in the isolated perfused rat liver. Hepatology 16: 1007-1013, 1992.
  pubmed

• 17) Jaeschke H, Schini VB and Farhood A: Role of nitric oxide in the oxidant stress during ischemia/reperfusion of the liver. Life Sci. 50: 1797-1804, 1992.
  pubmed

• 18) Linder L Kiowski W and Buhler FR: Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo;blunted response in essential hypertention. Circulation 81: 1762-1767, 1990.

• 19) Samuni A, Winkelsberg D and Pinson A: Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J. Clin. Invest. 87: 1526-1530. 1991.
  pubmed

• 20) 堀 正二, 北風政史, 高島成二・他: 心筋虚血におけるNO産生とその意義. 活性酸素の臨床への展望-NO(一酸化窒素)とSOD-(谷口直之 編集) , 医薬ジャーナル社, 大阪, 1994, pp. 29-35.

• 21) 工藤雅治, 渋木克栄: 脳とNO. 活性酸素・フリーラジカル 4: 513-521, 1993.

特別講演

P.13 掲載の参考文献

• 1) Palmer RMJ, Ferrige AG and Moncada S: Nitric oxide accounts for the biological activity of endothelium. derived relaxing factor. Nature 327: 524-526, 1987.

• 2) Zweifach BW, Kavalcheck S, Delano FA, Chen P: micropressure flow relationships in askeletal muscle of spontaneously hypertensive rats. Hypertension 3: 601-614, 1981.

• 3) Suematsu M, Nishino T, Schmid-Schonbein GW: Cancellation of nitric oxide-mediated microvascular flow regulation by xanthine oxidase-mediated oxidative stress in spantaneovsly hypertensive rats. Int. J Microcixc. Clin. Exp. 14: 22, 1994(abstract) .

• 4) Suzuki H, Suematsu M, Ishii H, et al: Prostaglandin EI abrogates early reductive stress and zone-specific oxidative injuny in hypoperfused rat liver. J Clin. Invest. 93: 155-164, 1994.

• 5) Stuehr DJ and Nathan CF: Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp. Med. 169: 1543-1555, 1989.

• 6) Suematsu M, Tamatani T, Delano FA, et al: Schmid-Schenbein GW. Micro-vascular oxidative stress preceding leukocyte activation elicited by in vivo nitric oxide suppression. Am. J. Physiol. 266(35) : H2410-H2415, 1994.

• 7) Patel KD, Zimmerman GA, Prescott SM, et al: 0xygen radicals induce human endo-thelial cells to express GMP140 and bind neutrophils. J. Cell Biol. 112: 749-759, 1991.

• 8) Kanner J, Harel S and Granit L: Nitric oxide, an inhibitor of lipid peroxidation by lipoxygenase. cyclooxygenase and hemoglobin. Lipids 27: 46 49, 1992.

Session 胃粘膜障害

P.17 掲載の参考文献

• 1) Warren JR and Marshall BJ: Unidentified curved bacilli on gastric epitheliuln in active chronic gastritis. Lancet i: 1273-1275, 1983.

• 2) Graham DY: Campylobacter pylori and peptic ulcer disease. Gastroenterology 96: 612-625, 1989.

• 3) Suzuki M, Miura S, Suematsu M, et al: Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am. J physiol. 263: G715-G725, 1992.

• 4) Akagi T and Kimoto T: Human cell line (HGC-27) derived from the metastatic lymph node of gastric cancer. Acta Med. Okayama 30: 215-217, 1976.
  pubmed

• 5) Tsujii M, Kawano S, Tsuji S, et al: Mechanism of gastric mucosal damage induced by ammonia. Gastroenterolgy 102: 1881-1888, 1992.

• 6) Brenes F, Ruiz B, Correa P, et al: Helicobacter pylori causes hyperproliferation of the gastric epithelium;pre-and post-eradication indices of proliferating cell nuclear antigen. Am. J. Gastroenterol. 88: 1870-1875, 1993.
  pubmed

• 7) Tsujii M, Kawano S, Tsuji S, et al: Cell kinetics of mucosal atrophy in rat stomach induced by long-term administration of ammonia. Gastroenterolog. 104: 796-801, 1993.

• 8) Kohli Y, Kato T, Yamazaki Y, et al: Effects of 0.02%or 0.11% NH3 solution on gastric mucosa in rats. J. Kyoto Pref. Univ, Med. 99: 1189-1197, 1990.

• 9) Parsonnet J, Friedman GD, Vandersteen DP, et al: Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325: 1127-1131, 1991.
  pubmed

P.22 掲載の参考文献

• 1) Nagamachi Y: New method of obtaining cinchophen ulcer in dogs. Am. J. Dig. Dis. 22: 761-768, 1977.
  pubmed

• 2) 小板橋宏: シンコフェンによるストレスのラット赤血球表面形態におよぼす影響. 北関東医学 42: 577-595, 1992.

• 3) 長町幸雄: 胃粘膜局所の物理的変化に対するセトラキセートの影響-実験潰瘍発生成因の面から-. 薬理と治療 11: 5181-5194, 1983.

• 4) Weltzien HU: Cytotoxic and membrane perturbing Properties of lysophosphatidylcholine. Biochim. Biophys. Acta 559: 259-273, 1979.

• 5) John Maksem MD, Neil Jacobson MD, Neiderhiser Rhd, et al: Lysophosphatidyl-choline-induced gastric injury and ulceratioll in the guinea pig. Am. J. Physiol. 115: 288-295, 1984.

• 6) Hirohara J, Sugatani J, Saito K, et al: Properties and localization of phospholipase A2 activity in rat stomach. Biochim. Biophys ACta 919: 231-238, 1987.
  pubmed

• 7) Zhang Y and Dennis EA: Purification and characterization of a lysophospholipase from a macrophage-like cell line P388D1. J. Biol. Chem. 263: 9965-9972, 1988.
  pubmed

• 8) Gross RW and Sobel BE: Rabbit myocardial cytosolic lysophospholipase. Purification, characterization, and competitive inhibition by L-palmitoyl carnitine. J. Biol. Chem. 258: 5221-5226, 1983.
  pubmed

• 9) Nagamachi Y: Significance of gastric mucosal pepsinogen and plasma corticosteroid levels in the course of cinchophen ulceration. Gastroenterol. Jpn. 12: 14-20, 1977.

• 10) Sugimoto H and Yamashita S: Purification, characterization, and inhibition by phosphatidic acid of lysophospholipase transacylase from rat liver. J Biol. Chem. 269: 6252-6258, 1994

P.27 掲載の参考文献

• 1) 澤井洋子, 今井重之, 荻原茂樹・他: 実験的ストレス潰瘍発生・進展過程における血小板, 凝固・線溶系の変動. 日血会誌 50: 470, 1987.

• 2) Paret RS, Kumashiro R, Kodama Y, et al: The effect of dipyridamole on experimentally induced stress ulcer. Am. Surg. 48: 594-596, 1982.
  pubmed

• 3) Kumashiro R, Montgomery O, Langman A, et al: The preventive effect of low dose aspirin in the development of stress ulceration in rats. Am. Surg. 49: 423-427, 1983.
  pubmed

• 4) Kumashiro R, Piotrowski J, Kholoussy AM, et al: Antiplatelet aggregator inhibit development of stress ulcers in sprague-dawley rats. Eur. Surg. Res. 17: 44-52, 1985.
  pubmed

• 5) Hirsh J and Brain EA: Hemostasis and Thrombosis. Churchill Livingstone, New York, 1983.

• 6) Maffrand JP, Bernat A, Delebassee D, et al: ADP plays a key role in thrombogenesis in rats. Thromb. J: Haemost. 59: 225-230, 1988.

• 7) 松田 保: 血栓形成と動脈硬化. 動脈硬化症研究の進歩(動脈硬化セミナー), Vol. 3, 医歯薬出版, 東京, 1982, pp. 3-50.

Session 胃粘膜防御機構

P.30 掲載の参考文献

• 1) Shimada M, Kitamura Y, Yokoyama M, et al: Spontaneous stomach ulcer in genetically mast-cell depleted W/WV mice. Nature 283: 662-664, 1980.
  pubmed

• 2) 春日井務, 森本将弘, 北村幸彦: マスト細胞毛欠損動物 c-kit レセプターとそのリガンドの異常. 細胞工学 10: 587-591, 1991.

• 3) Nocka K, Tan JC, Chiu E, et al: Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus;W37, WV, W41, and W. EMBO J 19: 1805-1813, 1990.

• 4) Yokoyama M, Tatsuta M, Baba M, et al: Bile reflux;A possible cause of stomach ulcer in nontreated mutant mice of W/WV genotype. Gastoenterology 82: 857-863, 1982.

• 5) Maeda H, Yamagata A, Nishikawa S, et al: Requirenlellt of c-kit for developnlent of intestinal pacemaker system. Development 116: 369-375, 1992.
  pubmed

• 6) Terano A, Shiga J, Hiraishi H, et al: Protective action of tetraprenylacetone against ethanol-induced damage in rat gastricmucosa. Digestion 35: 182-188, 1986.

• 7) Bilski J, Sarosiek J, Murty V L N, et al: Enhancement of the lipid content and physical properties of gastric mucus by geranylgeranylacetone. Biochem. Pharmacol. 36: 4059-4065, 1987.

• 8) Arakawa T, Yamada H, Nakamura A, et al: Gastric cytoprotection by tetraprenylacetone in human subjects. Digestion 39: 111-117, 1988.
  pubmed

P.36 掲載の参考文献

• 1) 友永健治, 長畑洋司, 斎藤洋一: 膵疾患と胃の相関. 消化器血流の研究 8(消化器血流研究会編), 第1版, メディカルトリビューン, 東京, 1992, pp. 69-73.

• 2) 藤原元始, 森 襄: 実験的stress胃潰瘍とAmine. 最新医学 25: 2058-2067, 1970.

• 3) 石原和彦, 森下 薫, 小原 進・他: 胃粘液含量測定法としての胃粘膜ヘキソサミン定量の妥当性についての検討. 日消誌 86: 111, 1989.

• 4) 水本龍二, 伊佐地秀司, 佐藤芳邦: 急性膵炎とmultiple organ failure. 胆と膵 5: 309-316, 1984.

• 5) 香川修司, 裏川公章, 斎藤洋一: 急性膵炎時の胃病変発生機序についての実験的研究. 神大医紀 47: 169-177, 1986.

• 6) 阿部道夫: 胃膵相関の臨床. 医学のあゆみ 105: 917-923, 1978.

• 7) 岡田正典, 塚本純久, 中澤三郎: 急性膵炎に伴なう急性胃粘膜障害に関する実験的研究. 日消誌 81: 2568-2576, 1984.

• 8) 八田 敏: ストレス潰瘍発生時の自律神経に関する実験的研究-胃壁血流量および胃運量の測定より-. 日外会誌 82: 1212-1223, 1981.

• 9) 大川博之, 小原 進, 石原和彦・他: 酸分泌刺激剤及び塩酸のラット胃粘膜粘液糖タンパク質に及ぼす影響. 日消誌 86: 1369-1375, 1988.

• 10) 村上 学, 若林庸夫: テプレノンの開発. Pharma. Medica, 4: 91-99, 1986.

P.40 掲載の参考文献

• 1) Miller TA: Protective effects of prostaglandins against gastric mucosal damage, current knowledge and proposed mechanisms. Am. J. Physiol. 245: G601-G625, 1983.
  pubmed

• 2) Ota H, Katsuyama T, Ishii K, et al: Adual staining method for identifying mucins of different gastric epithelial mucous cells. Histochem. J. 23: 22-28, 1991.

• 3) Hattori T: On cell proliferation and differentiation of the fundic mucosa of the golden hamster. Cell Tiss. Res. 148: 213-226, 1974.

• 4) 浅田修二: 画像処理装置(VIP)による胃粘液量の検討. 大阪医大誌 46: 62-76, 1987.

• 5) Bolton JP, Palmer D and Cohen MM: Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins. Am. J. Dig. Dis. 23: 359-364, 1978.
  pubmed

• 6) Johansson C and Kollberg B: Stimulation by intragastrically administered E2 prostaglandins of human gastric mucus output. Eur. J. Clin. Invest. 9: 229-232, 1979.
  pubmed

• 7) 梅垣英次, 滝内比呂也, 浅田修二・他: 粘液溶解剤のエタノール胃病変および胃粘液に及ぼす影響. Ulcer Research 19: 80-84, 1992.

• 8) 滝内比呂也: 胃粘膜保護作用における粘液の役割に関する実験的研究. 大阪医大誌 52: 45-52, 1993.

• 9) Robert A, Nezamis JE, Lancaster C, et al: Cytoprotection by prostaglandins in rats, prevention of gastric necrosis produced by alchol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77: 433-443, 1979.

• 10) Lacy ER and Ito S: Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prosta glandin. Gastroenterology 83: 619-625, 1982.

P.42 掲載の参考文献

• 1) Cohen S : Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new born animal J. Biol. Chem. 237:1555-1562, 1962.
  pubmed

• 2) Konturek SJ, Radeci T, Brzozowskl T, et al: Gastric cytoprotection by epidemal growth factor. Role of endogenous prosta glandins and DNA synthesis. Gastroenterology 81: 438 443, 1981

• 3) Koturek SJ, Dembms ki A, Warzecha Z, et al: Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 94: 1300-1307, 1988

• 4) Konturek SJ, Cleszkowski M, Jaworek J, et al: Effects of epidermal growth factor on gastrointestinal secretion. Am. J. Physiol. 246: G580-586, 1984.

• 5) Watanabe S, Wang X, Hirose M, et al: Effect of myosin light chain kinase inhibitor wortmannin on the wound repair of cultured gastric mucosal cells. Biochem. Biophys. Res. Commun. 199: 799-806, 1994.
  pubmed

• 6) Watanabe S, Hirose M, Wallg X, et al: Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells. Biochem. Biophys. Res. 199: 1453-1460, 1994.

P.48 掲載の参考文献

• 1) Karam SM and Lebond CP: Dynamics of epithelial cells in the corpus of the mouse stomach. 1. Identification of proliferative cell types and pinpointing of the stem cell. Anat. Rec. 236: 259-279, 1993.

• 2) Karam SM and Lebond CP: Dynamics of epithelial cells in the corpus of the mouse stomach. 2. Outward migration of pit cells. Anat. Rec. 236: 280-296, 1993.

• 3) Karam SM and Lebond CP: Dynamics of epithelial cells in the corpus of the mouse stomach. 3. Inward migration of neck cells followed by progressive transformation into zymogenetic cells. Anat. Rev. 236: 297 313, 1993.

• 4) Karam SM and Lebond CP: Dynamics of epithelial cells in the corpus of the mouse stomach. 4. Bidirectional migration of parietal cells ending in their gradual degeneration and loss. Anat. Rec. 236: 314-332, 1993.

• 5) Karam SM and Lebond CP: Dynamics of epithelial cells in the corpus of the mouse stomach. 5. Behavior entero-endocrine and caveolated cells;general conclusions on cell kinetics in the oxyntic epithelium. Anat. Rec. 236: 333-340, 1993.

• 6) Hattori K, Sakano Y, Fujita S, et al: Tritiated thymidine autoradiographic study on cellular migration in the gastric glands of the golden hamster. Cell Tissue Res. 172: 171-184, 1976.

• 7) Terano A, Ivey KJ, Stachura J, et al: Cell culture of rat gastric fundic mucosa. Gastroenterology, 83: 1280-1291, 1982.
  pubmed

• 8) Nakamura K, Rokutan K, Marui N, et al: Induction of heat shock proteins and their implication in protection against ethanol induced damage in cultured guinea pig gastric mucosal cells. Gastroenterology 101: 161-166, 1991.
  pubmed

• 9) Katsuyama T, Ono K, Nakayama J, et al: Recent advances in mucosubstance histochemistry. Gastric mucus and mucus secreting cells(edited by Kawai K) , Excerpta Medica, Tokyo, 1985, pp. 3-18.

• 10) Sarosiek J, Bilski J, Murty VLN, et al: Role of pshycochemical characteristics of oral and gastric mucosal coat., Biochem. Biol Res. Commun. 152: 1421-1427, 1988.

P.52 掲載の参考文献

• 1) Narita T, Koide Y, Yaguchi S, et al: An-titumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis (2,6. dioxopiperazine) . Carcer Chemother, Pharmacol. 28: 235-240, 1991.

• 2) 正岡 徹, 陰山 克, 巽 典之・他: MST-16 (Sobuzoxane) の悪性リンパ腫に対する後期臨床第II相試験. 癌と化学療法 19: 339-347, 1992.
  Medical*Online

• 3) Harman EH, Ferrens VJ, Young RSK, et al: Effect of pretreatment with ICRF-187 on the total culnulative dose of doxorubicin tolerated by beagle dogs. Cancer Rev. 48: 6918-6925, 1988.

• 4) Chou TC and Talalay P: Applications of themedian-effect principle for the assessment of low-dose risk of carcinogens and for the quantitation of synergism and antagonism of chemotherapeutic agents. Bristol Meyers Cancer Symposia 8: 37-64, 1987.

• 5) Wadler S, Green DM and Basch R: Lethal and sublethal effects of the combinatin of doxorubicin and the bisdioxopiperazine, (+) -1, 2, -bis (3-5-dioxopiperazinyl-1-yl) propane(ICRF-187) on murine sarcoma S180 in vivo. Biochem. Pharmacol. 36: 1495-1501, 1987.

• 6) Hasinoff BB: The interaction of cardioprotective agent ICRF-187 ((+) -1, 2bis(3, 5-dioxopiperazinyl-1-ly) propane) ;its hydrolysis product(ICRF-198) ;and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin. Agents Actions 26: 378-385, 1989.

• 7) Ishida R, Miki T, Narita T, et al: Inhibition of intracellular topoisomerase II by antitumor bis (2, 6-dioxopiperazine) derivatives;mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors. Cancer Res. 51: 4909-4916, 1991.
  pubmed

P.56 掲載の参考文献

• 1) 佐藤英章, 森 吉臣: シスプラチンの腎尿細管傷害に対するソルコセリルの保護効果における実験的研究. 癌と化学療法 19: 89-93, 1992.
  Medical*Online

• 2) 川俣建二, 立川 勲, 渡辺 徹: 制癌剤とSolcoserylの併用. 新薬と臨床 13: 45-46, 1964.

• 3) 佐丸義夫, 花田佐智代: C3H/He マウス同系 MM2 腹水腫瘍に対するソルコセリルの制癌効果について. 基礎と臨床 15: 215-220, 1981.

• 4) 岩佐 博, 三村一夫, 大崎裕子・他: マウス Meth-A 腫瘍に対するソルコセリルおよび FT-207 の併用効果について. 癌と化学療法 10: 254-260, 1983.
  Medical*Online

P.60 掲載の参考文献

• 1) 宮本 要, 菱沼宇春, 永川純一・他: 合成 Protease inhibitor(E-3123) の実験的急性膵炎に対する効果. 日薬理誌 91: 285-293, 1988.
  Medical*Online

• 2) Iwatsuki K, Horiuchi A, Yonokura H, et al: E-3123, A new synthetic protease inhibitor, protects against deoxycholic acid-induced acute pancreatitis in dogs. Arch. Int. Pharmacodyn. Ther. 308: 168-177, 1990.

• 3) Hirano T, Manabe T, Yotsumoto F, et al: Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats;protective effect of a potent new protease inhibitor, E-3123. Nippon Geka Hofean 61: 234-248, 1992.

• 4) Adler G, Harn C, Kern H, et al: Caerulein-induced pancreatitis in rats;increased lysosomal enzyme activity and autophagocytosis. Digestion 32: 10-18, 1985.

• 5) Adler G, Rohr G and Kern H: Alteration of membrane fusion as a cause of acute pancreatitis in the rat. Dig. Dis. Sci. 27: 993-1102, 1982.
  pubmed

• 6) Lampel M and Kern HF: Acute Interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows. Arch [A] 373: 97-117, 1977.
  pubmed

• 7) 谷 聡, 大槻 眞, 藤井正俊・他: ラットにおける caerulein 皮下投与による実験的急性浮腫性膵炎の経時的変化. 膵臓 1: 243-249, 1986.

• 8) 小池台介, 寺沢憲一, 建部高明・他: 大量の caerulein をラットに皮下投与して作製した急性間質性膵炎. 膵臓 1: 44-50, 1986.

• 9) 船越顕博, 自見厚郎, 古川正幸・他: セルレイン急性膵炎に対する新しい蛋白分解酵素インヒビター(E-3123) の予防効果. 臨と研 66: 3313-3318, 1989.
  Medical*Online

• 10) Hirano T, Manabe T, Imanishi K, et al: A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis. Nippon Geka Hofean 60: 406-414, 1991.

P.64 掲載の参考文献

• 1) Abecassis M, Falk R, Blendis L, et al: Treatment of fulminant hepatic failure with a continuous infusion of prostin VR(PGE1) . Hepatology 7: 1104(Abstract) , 1987.

• 2) Greig PD, Woolf GM, Sinclair SB, et al: Treatment of primary liver graft nonfunction with prostaglandin E1. Transplantation 48: 447-453, 1989.
  pubmed

• 3) Robert A: Cytoprotection by prostaglandins. Gastroenterology 77: 761-767, 1979.
  pubmed

• 4) 石井良知: ケノデオキシコール酸の培養ラット肝細胞に及ぼす影響とProstaglandin E1の細胞保護効果について. 日消誌 82: 108-117, 1985.

• 5) 宇田川郁夫, 宮崎 勝, 越川尚男・他: 部分肝阻血時の肝ライソゾーム膜脆弱性より見た肝細胞障害およびプロスタグランジンE1誘導体の影響. 日外会誌 93: 288-294, 1992.

• 6) Fanton JC and Kinnes DA: Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils. Biophys. Res. Commun. 113: 506-512, 1983.

• 7) Mizoguchi Y, Tsutsui H, Miyajima K, et al: The protective effect of prostaglandin E, in an experimental massive hepatic cell necrosis model. Hepatolog J, 7: 1184-1188, 1987.

• 8) Geumei A, Bashour FA, Swamy BV, et al: Prostaglandin E1;Its effects on hepatic circulation in dogs. Pharmacology 9: 336-347, 1973.
  pubmed

• 9) Golub M, Zia P, Matsuno M, et al: Metabolism of prostaglandin AI and E, in man. J Clin. Invest. 56: 1404-1410, 1975.

• 10) Richardson PD and Withrington PG: Liver Blood Flow II. Effects of drugs and hormones on liver blood flow. Gastroenterology 81: 356-375, 1981.
  pubmed

P.68 掲載の参考文献

• 1) Fujiwara K, Ogata I, Oka H, et al: Insulin and glucagon therapy of acute hepatic failure., Dig. Dis. Sci 36: 809-815, 1991.

• 2) 石井良知: ケノデオキシコール酸の培養ラット肝細胞に及ぼす影響と, Prostaglandin E1の細胞保護作用について. 日消病会誌 82: 108-117, 1985.

• 3) Carlson L, Irion E, Oro L, et al: Effect of infusion of prostaglandin E1, on the aggregation of blood platelets in man. Life Sci. 7: 85 89, 1968.

• 4) Mizoguchi Y, Tsutsui H, Miyajima K, et al: The protective effects of prostaglandin E, in an experimental massive hepatic cell necrosis model. Hepatology 7: 1184-1188, 1987.

• 5) Konno T, Maeda H, Iwai K et al: Effect of arterial adminstration of high-molecular weight anticancer agent on hepatoma;a preliminary report. Eur. J. Cancer Clin. Oncol. 19: 1053-1065, 1983.

• 6) Abecassis M, Fal R, Blendis L, Levy G, et al: Treatment of fulminant hepatic failure with continuous infusion of prostin VR (PGE1) . Hepatology 7: 1104 (abstract) , 1987.

• 7) 森岡秀之.: 肝硬変症における肝再生と体液性肝再生因子受容体との関連. 日外宝 55: 403-414, 1986.

• 8) Mizoguchi Y, Ichikawa Y, Kobayashi K, et al: The effect of lipo-prostaglandin E, on the production of interleukin 1 and platelet-activating factor by hepatic sinusoidal endothelial cells in mice. Osaka City Med. J. 37: 69-78, 1991.
  pubmed

• 9) 江角凱夫, 三次孝一, 河野喜郎・他: 3H-Lipo PGE1の吸収, 分布, 代謝および排泄. 基礎と臨床 20: 4399-4428, 1986.
  Medical*Online

• 10) 佐々木国夫, 長村洋一, 斎藤邦明・他: 単離ラット肝細胞によるリポゾームの取り込みに於けるリン脂質の役割(短報). 藤田学園医会誌 10: 79-82, 1986.

• 11) 松崎靖司, 池上 正, 大菅俊明・他: 重症肝不全症例におけるLipo PGE1の使用経験. 第3回関東MMC研究会抄録集, 1992, pp. 11-12.

P.72 掲載の参考文献

• 1) Kane ABD, Petrovich R, Stern O, et al: ATP depletion and the loss of cell integrity in anoxic hepatocytes and silica-treated p388 D1 macrophage. Am. J. Physiol. 249: C256-C266, 1985.

• 2) Gunn MDA, Sen YM, Chang A, et al: Mechanism of accumulation of arachidonic acid in cultured myocardial cells during ATP depletion. Am. J. Phisiol. 249: H1188-H1194, 1985.

• 3) Nicotera P, Hartzell P, Baldi C, et al: Cystamine induces toxicity of hepatocytes through the elevation of cytosolic Ca2+ and the stimulation of a nonlysosomal proteolytic system. J. Biol. Chem. 261: 14628-14636, 1986.
  pubmed

• 4) Masaki N, Sakaida I and Farber JL: Protease inhibitors do not prevent the killing of cultured hepatocytes by cystamine. Biochem. Biophys. Res. Commun. 163: 412-417, 1990.
  pubmed

• 5) Sakaida I, Thomas AP and Farber JL: Phospholipid metabolism and intracellular Ca2+homeostasis in cultured rat hepatocytes intoxicated with cyanide. Am. J, Physiol. 263: C684-C690, 1992.
  pubmed

• 6) Sakaida I, Thomas AP and Farber JL: In-Crease in cytosolic Calcium ion concentration can be dissociated from the killing of cultured hepatocytes by tert-butyl hydroperoxide. J. Biol. Chem. 266: 717-722, 1991.

• 7) Nicholus JC, Bronk SF, Ronald LM and Gores GJ: Inhibition of nonlysosomal calcium-dependeny proty proteolysis by glycine during anoxic injury of rat hepatocytes. Gastroenterology 106: 168-176, 1994.

• 8) Sakaida I, Okita K and Farber JL: Protection by glycine against ischemia(cyanide) is not due to reduction in intracellular pH. (submitted. )

P.75 掲載の参考文献

• 1) 中嶋俊彰: 肝における摂取, 生成, 代謝, 放出機構-胆汁酸. 日本臨牀(肝胆疾患, 上) 569: 136 142, 1988.

• 2) Scholmerich J, Becher M, Schmidt K, et al: Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties. Studies on isolated hepatocytes and lipid membrane vesicles. Hepatology 4: 661-666, 1984.
  pubmed

• 3) 中嶋俊彰, 瀬戸良文, 中川義弘・他: 非抱合, glycine 抱合型および taurine 抱合型胆汁酸による細胞膜の変化- 31P-NMR法による解析. 含硫アミノ酸 8: 202-208, 1985.

• 4) Greim H, Trulzsch D, Roboz J, et al: Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology 63: 837-845, 1972.
  pubmed

• 5) Nakashima T, Shima T, Sakamoto Y, et al: Effects of bile acids and taurine on the lipid fluidity of hepatic microsomes in normal and bile duct-ligated rats-A spin label study. J. Hepatol. 18: 74-79, 1993.
  pubmed

• 6) Gaffney BJ: Fatty acid chain flexibility in the membranes of normal and transformed fibroblasts. Proc. Natl. Acad. Sci. USA 72: 664-668, 1975.
  pubmed

• 7) Kawata S, Chitranukroh A, Owen JS, et al: Membrane lipid changes in erythrocytes, liver and kidney in acute and chronic experimental liver disease in rats. Biochim Biophys. Acta 896: 26-34, 1987.
  pubmed

• 8) Bengochea L, Ouvina G, Sozzani P, et al: Protein and lipid disturbances in rat liver microsomal membranes after bile duct ligation. Biochem. Biophys. Res. Commun. 144: 980-985, 1987.
  pubmed

• 9) Nakashima T, Sano A, Nakagawa Y, et al: Effect of taurine on the course of drug-induced chronic liver disease. In Sulfur Amino Acids, Biochemical and Clinical Aspects (edited by Kuriyama K, Huxtable RJ and Iwata H) , Alan R. Liss, New York, 1983, p. 472.

• 10) Nakashima T, Seto Y, Nakajima T, et al: Calcium-associated cytoprotective effect of taurine on the calcium and oxygen paradoxes in isolated rat hepatocytes. Liver 10: 167-172, 1990.
  pubmed

P.81 掲載の参考文献

• 1) Thurman RG, Marzi I, Zimmerman F, et al: Hepatic reperfusion injury following orthotopic liver transplantationin the rat. Transplantation 46 : 502-506, 1988.

• 2) Shiratori Y, Kawase T, Kamii K, et al: Superoxide allion production and lysosolnal enzyme activities of Kupffer cells in galactosamine induced hepatitis;correlation to endotoxemia and hepatic injury(edited by Kirn A, Knook DL and Wisse E) Vol. 1, Cells of the Hepatic Sinusoid, 1986, pp. 349-356.

• 3) 桐山弘喜, 名倉 徹, 上原兼宗, 上井一男: 虚血・再灌流時におけるKupffer細胞の関与. Cyto-protection & biology 11: 57-60, 1993.

• 4) Shiratori Y, Geerts A, Wisse E, et al: Kupffer cells from CCl4-induced fibrotic livers stimulate proliferation of fat-storing cells. J Hepatology 3: 294 303, 1986.

• 5) Lazar G, Van Galen M and Scherphof GL: Gadoliniuni chloride-induced shifts in intrahepatic distributiolls of liposolnes. Biochim. Biophys. Acta 1011: 97-101, 1989.
  pubmed

• 6) Shiratori Y, Matsumoto K, Kamii K, et al: Modulation of hepatotoxicity by macrophages in the liver. Hepatology 8: 815-821, 1988.
  pubmed

• 7) Van Dyke K, Trush M, Miles P, et al: Lumillol dependent chemiluminescence analysis of cellular and humoral defects using a chemglo photolneter. Microchemical J 22: 463-474, 1977.

• 8) Ueno I, Kohno M, Kanegasaki S, et al: Revaluation of the spin-trapped adduct formed from 5,5-dimethyl-1-pyrroline-1-oxide during the respiratory burst in neutrophils. J. Biochem. (Tokyo) 105: 905-910, 1989.

• 9) Farber JL: The role of calcium in cell death. Life Sci. 29: 1289-1295, 1981.
  pubmed

• 10) Granger DN, Rutili G and McCord JM: Role of superoxide radicals in feline intestinal ischemia . Gastroenterology 81: 22-29, 1981.
  pubmed

• 11) Engerson TD, McKelvey TG, Jones HP, et al: Conversion of xanthine dehydrogellase to oxidase in ischemicrat tissues. J. Clin. Invest. 79 : 1564-1570, 1987.
  pubmed

• 12) Engler RL, Dahlgren MD, Schmid-Schonbein GW, et al: Accumulation of polymorphonuclear leukocytes during 3 h experimental myocardial ischemia. Am. J. Physiol. 251 (Heart Circ. Physiol. 20) : 93-100, 1986 .

• 13) Metzger J, Dore SP and Lauterburg BH: Oxidant stress during reperfusion of ischenlic liver;no evidecce for a role of xanthine oxidase. Hepatology, 8: 580-584, 1988.
  pubmed

P.86 掲載の参考文献

• 1) Flamm ES, Demopoulos HB, Seligman ML, et al: Free radicals in cerebral ischemia. Stroke 9: 445-447, 1978.
  pubmed

• 2) Demopoulos HB, Flamm ES, Pietronigro DD, et al: The free radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol. Scand. 492 (Suppl. ) : 91-118, 1980.
  pubmed

• 3) Demopoulos HB, Flamm ES, Seligman ML, et al: Molecular pathology of lipids in CNS membranes. In Oxygen and physiological function (edited by Jobsis FF) , Professional Information Library, Dallas, 1977, pp. 491-508.

• 4) Gotoh O, Asano T, Tamura A, et al: Ischemic brain edema and the glutathione system. In Intracranial pressure V(edited by Ishii S and Nagai H) , Springer-Verlag, Berlin-Heidelberg, 1983, pp. 399-402.

• 5) Yoshida S, Abe K, Busto R, et al: Influence of transient ischemia on lipid soluble antioxidants, free fatty acids and energy metabolites in rat brain. Brain Res. 245: 307-316, 1982.
  pubmed

• 6) Kanemitsu H, Tamura A, Sano K, et al: Changes of uric acid level in rat brain after focal ischemia. J. Neurochem. 46: 851-853, 1986.
  pubmed

• 7) Oka H, Kanemitsu H, Nihei H, et al: Change of xanthine dehydrogenase and xanthine oxidase activities in rat brain following complete ischemia. Neurol. Res. 14: 321-324, 1992.
  pubmed

• 8) Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite;implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624, 1990.
  pubmed

• 9) Fridovich I: Superoxide dismutases. Ann. Rev. Biochem. . 44: 147-159, 1975.
  pubmed

• 10) Dudnik LB, Tikhaze AK, Alesenko AV, et al: Changes of superoxide dismutase and glutathione peroxide activity during intensification of lipid peroxideation in ischemia of the liver. Bull. Exp. Biol. Med. 91: 451-453, 1981.

• 11) Julicher RHM, Tijburg LBM, Sterrenber L, et al: Decreased defense against free radicals in rat heart during normal reperfusion after hypoxic ischemic and calcium-free perfusion., Life Sci. 35: 1281-1288, 1984.

• 12) Tamura A, Graham DI, McCulloch J, et al: Focal cerebral ischemia in the rat;1. Description of technique and early neu-ropathological consequences following middle cerebral artery occlusion. J, Cereb. Blood Flot Metab. 1: 53-60, 1981.

• 13) 河野雅弘: ESR法によるスーパーオキサイドの分析. Lab. Clin. Pract. 7: 65-71, 1989.

• 14) McCord JM and Fridovich I: Superoxide dismutase;an enzymatic function for erythrocuprein(hemocuprein) . J. Biol. Chem. 244: 6049-6055, 1969.

• 15) 河野雅弘: 活性酸素種とSODの定性・定量, ESR-スピントラップ法による. 組織培養 14: 132-136, 1988.

• 16) Bodannes RS and Chan PC: Ascorbic acid as a scavenger of singlet oxygen. FEBS Lett. 105: 195-196, 1979.
  pubmed

• 17) Cooper AJL, Pulsinelli WA and Duffy TE: Glutathione and ascorbate during ischemia and post-ischemic reperfusion in rat brain. J. Neurochem. 35: 1242-1245, 1980.

• 18) Nishikimi M and Yagi K: Oxidations of ascorbic acid and α-tocopherol by superoxide. In Biochemical and medical aspects of active oxygen(edited by Hayaishi O and Asada K) , University Park Press, Baltimore, Maryland, 1975, pp. 79-87.

• 19) Rehncrona S, Folbergrova J, Smith DS, et al: Influence of complete cerebral ischemia and subsequent recirculation on cortical concentrations of oxidized and reduced glutathione in the rat. J. Neurochem. 34: 477-486, 1980.

• 20) Gotoh O, Asano T, Koide T, et al: Ischemic brain edema following occlusion of the middle cerebral artery in the rat. 1. The time courses of the brain water, sodium, and potassium contents and blood-brain-barrier permeability to 1251-albumin. Stroke 16: 101-109, 1985.

P.94 掲載の参考文献

• 1) 大田和夫: 移植医療と社会. 医学のあゆみ 164 (6) : 442-446, 1993.

• 2) Ogawa S, Koga S, Kuwabara K, et al: Hypoxia-induced increased permeability of cultured bovine pulmonary and aortic endothelial monolayers occurs through lowering of cellular cAMP levels and is modulated by glucocorticoids. Am. J. Physiol. 262: C546-554, 1992.

• 3) Stelzner T, Weil J and O'Brien: Role of cyclic adellosille nionophosphate in the induction of endothelial barrier properties. J. Cell Physiol 139: 157. 166, 1989.

• 4) Seibert A, Thompson W, Taylor A, et al: Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP. Appl. Physiol. 72: 389-395, 1992.
  pubmed

• 5) Haynes J, Robinson J, Saunders L, et al: Role of cAMP-dependent protein kinase in cAMP-mediatedvasodilation., Am. J Physiol 262: H511-516, 1992.

• 6) Koga S, Ogawa S, Kuwabara K, et al: Synthesis and release of interleukin-1 by reoxygenated human mononuclear phagocytes. J Clin. Invest. 90: 1007 1015, 1992.

• 7) Suttorp N, Weber U, Welsch T, et al: Role of phosphodiesterase in the regulation of endothelial permeability in vitro. J. Clin. Invest. 91: 1421 1428, 1993.

• 8) Corbin J, Ogreid D, Miller J, et al: Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase. J Biol. Chem. 261: 1208-1214, 1986.
  pubmed

• 9) Koga S, Han D, Kline R P, et al: Electrical evaluation of myocardial viability following prolonged storage of explanted hearts. Circulation 86(4) : I-770, (Abstr) , 1992.

• 10) Pinsky D, Koga S, Oz M, et al: Failure of endogenous vasodilation contributes to car diac graft failure following prolonged storage. Circulation 86(4) : I-763, (Abstr) , 1992.

• 11) Oz M, Pinsky D, Koga S, et al: Enhanced donor heart preservation with a novel cAMP based solution Circulation 86(4) : I-840, (Abstr) , 1992.

P.98 掲載の参考文献

• 1) Jeevanandam V, Barr M, Auteri J, et al: University of Wisconsin solution for human donor heart preservation;Initial clinical experience. Ann. Thorac. Surg. 52: 1213. 1216, 1991.

• 2) 砂盛 誠: 開心術における心筋保護. 第1版, 医歯薬出版, 東京, 1990, pp. 141-156.

• 3) Wicomb W, Hill J, Avery J, et al: 0ptimal cardioplegia and 24-hour heart storage with simplified UW solution containing polyethylene glycol. Transplantation 48: 6-9, 1990.

• 4) Ledingham S, Katayama O, Lachno D, et al: Prolonged cardiac preservation;Evaluation of the University of Wisconsin preservation solution by comparison with the St. Thomas' Hospital cardioplegic xolutions in the rat. Circulation 82 (Suppl. IV) : IV 351-358, 1990.

• 5) Sunamori M, Trout RG, Kaye MP, et al: Quantitative evaluation of myocardial ultrastracture following hypothermic anoxic arrest. J. Thorac. Cardiovasc. Surg. 76: 518-527, 1978.

• 6) Yoshida T, Sunamori M, Miyamoto H, et al: Comparison of intermittent injection with a single-flushed UW solution for donor heart preservation. Transplant. Proc. 25: 3201-3204, 1993.
  pubmed

P.103 掲載の参考文献

• 1) Kobayashi M: A 24 hour lung storage using low potassium UW solution. Acta Med. Nagasalei Ensia. 37: 222-228, 1992.

• 2) 井出誠一郎, 川原克信, 高橋孝郎・他: 保存肺の 再灌流障害におけるPAF拮抗剤(TCV-309)の有用性の検討. Cyto-protection & biology 11: 139-142, 1993.

• 3) Veith FJ, Richard K, et al: Improved technique for canine lung transplantation. Ann. Surg. 171: 553, 1970.

• 4) Prop J, Ehrie M, Crapo J, et al: Reimplantation respose in isografted rat lungs. J. Thorac. Cardiovasc. Surg. 87: 702-711, 1984.

• 5) Kawahara K, Ikari H, Hisano H, et al: Twenty-four hour canine lung Preservation using solution. Transplantation 51: 584-587, 1991.
  pubmed

• 6) Devine CE, Somylo AV, Somylo AP, et al: Sarcoplasmic reticulum and excitation-conraction coupling in mammarian smooth muscle. J. Cell Biol. 52: 690, 1972.

• 7) Sasaki N, Kawahara K, Takahashi T, et al: Function of canine lung allografts preserved by modified University of Wisconsin solution for 24 hours. Transplant. Proc. 26: 837-875, 1994.

• 8) Oka T, John D, Eckhard M, et al: Low Potassium UW solution for lung Preservation. Transplantation 52: 984-988, 1991.

• 9) Foegh ML, Chambers E, Khirabadi BS, et al: PAF in organ transplant rejection. Adv. Prostaglandin Thromboxane Leukotriene Res. 19: 377-381, 1989.

• 10) Tagawa T, Kawahara K, Takahashi T, et al: Effect of platelet-activating factor antagonist TCV-309 on 24 hr canine lung preservation. CYTOPROTECTION and CYTOBIOLOGY 10: 129-137, 1992.

P.108 掲載の参考文献

• 1) Fujita H, Morita I and Murota S: Involvement of adhesion molecule (CD11a ICAM-1) in vascular endotherial cell injury elicited by PMA-stimulated neutrophils. Biochem. Biophys. Res. Commun. 177: 664-672, 1991.

• 2) Yoshida N, Granger DN, Anderson DC, et al: Molecular determinants of aspirin-induced neutrophil adherence to endotherial cells. Gastroenterology 105: 715-724, 1993.

• 3) Hernandez LA, Grisham MB, Twohig B, et al: Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am. J. Physiol . 238: H699-H703, 1987.

• 4) 片山 敏, 角田 創, 佐久間義範・他: Azelastineのロイコトリエン産生・遊離抑制作用およびロイコトリエン拮抗作用. Prog. Med. 6: 1173-1178, 1986.
  Medical*Online

• 5) 赤木正明, 見尾光庸, 田坂賢二・他: Azelastineのhistamine遊離抑制機序. 応用薬理 26 : 191-198, 1983.

P.114 掲載の参考文献

• 1) Furchgott RF and Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
  pubmed

• 2) Palmer RMJ, Ferrige, AG and Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.

• 3) Ignarro LJ: Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41: 485-490, 1991.
  pubmed

• 4) Naito Y, Yoshikawa T, Kaneko T, et al: Synergism between superoxide dismutase (SOD) and nitric oxide in gastric mucosal protection following ischemia-reperfusion in rats. Free Radic. Res. Commun. 16: 13-15, 1992.

• 5) Pique JM, Whittle, BJR and Esplugues JV: The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur. J. Pharmacol. 174: 293-296, 1989.

• 6) Walder CE, Thiemermenn C, Walder C, et al: Endothelium-derived relaxing factor participates in the increased blood flow in response to pentagastrin in the rat stomach mucosa. Proc. R. Soc. Lond. (Biol) 241: 195-200, 1990.

• 7) Pique JM, Esplugues JV and Whittle JR: Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion. Gastroenterology, 102: 168-174, 1992.

• 8) Kitagawa H, Takeda F and Kohei H: Effect of endothelium-derived relaxillg factor on the gastric lesion induced by HCl in rats. J. Pharmacol. Exp. Ther. 253: 1133-1137, 1990.
  pubmed

• 9) MacNaughton WK, Cirino G and Wallace JL: Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci. 45: 1869-1876, 1989.
  pubmed

• 10) Whittle BJ, Lopez BJ and Moncad, S: Regulation of gastric mucosal integrity by endogenous nitric oxide;interactions with prostanoids and sensory neuropeptides in the rat. Br. J. Pharmacol. 99: 607-611, 1990.

• 11) Peskar BM, Respondek M, Muller KM, et al: A role of nitric oxide in capsaicin-in-duced gastroprotection. Eur. J. Pharmacol. 198: 113-114, 1991.

• 12) Konturek SJ, Brzozowski T, Majka, J, et al: Role of nitric oxide and prostaglandills in sucralfate-induced gastroprotection. Eur. J. Pharmacol. . 211: 277-279, 1992.
  pubmed

• 13) Clancy RM, Leszczynska-Piziak J and Abramson SB: Nitric oxide, an endothelial cell relaxation factor, inhibit neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90: 1116-1121, 1992.

• 14) Kubes P, Suzuki M and Granger DN: Nitric oxide;an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651-4655, 1991.
  pubmed

• 15) Sanders KM and Ward SM: Nitric oxide as amediator of nonadrenergic noncholinergic neurotransmission. Am. J. Physiol. 262: G379-G392, 1992.
  pubmed

P.117 掲載の参考文献

• 1) Tsuji S, Kawano S, Sato N, et al: Mucosal blood flow stasis and hypoxemia as the pathogenesis of acute gastric mucosal injury. J. Clin. Gastroenterol. 12(SuppL1) : S85-S 91, 1990.

• 2) Furchgott RF and Zawadzki JV: The obligatory role of endothelial cell in the relaxation of arterial smooth muscle by acetyl-choline. Nature 288: 373-376, 1980.

• 3) Kitagawa H, Takeda F and Kohei H: EndotheliunTdependent increases in rat gastricmucosal hemodynamics induced by acetylcholine and vagal stimulation. Eur. J. Pharmacol. 133: 57-64, 1987.

• 4) Sato N, Kawano S, Tsuji S, et al: Physiological and pathological respollses in the gastric mucosal blood flow. In Mechanisms of Injury, Protection and Repair of the Upper GI Tract (edited by Garner A and O'Brien PE) , John Wiley & Sons, Chichester, 1991, pp. 299-308.

• 5) Palmer RM, Ferrige AG and Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. J Nature 327: 524-526, 1987.

• 6) Peng HB, Kawano S, Tsuji S, et al: Effects of NG-monomethyl-L-arginine on systemic and gastric circulation in anesthetized rats. In Microcirculation Annual(edited by Tsuchiya M, Asano M and Ohshima N) , Nihon-Igakukan, Tokyo, 1992, pp. 49-50.

• 7) Radomski MW, Palmer RM and Modaca S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87: 10043-10047, 1990.

• 8) Tsuji S, Kawano S, Masuda E, et al: Ethanol stimulates immunoreactive endo-thelin-1 and-2 release from cultured human umbilical vein endothelial cells. Alcohol Clin. Exp. Res. 16: 347-349, 1992.

P.121 掲載の参考文献

• 1) 井上正康: グルタチオン代謝と膜輸送の臓器相関. 蛋白質 核酸 酵素 29: 695-707, 1984.

• 2) Frank T: Enzymic method for quantitative determination of nanogram anlounts of total and oxidized glutathioe;Application to mammalian blood and other tissues. Anal. Biochem. 27: 502-522, 1969.

P.126 掲載の参考文献

• 1) Ichimori K, Ishida H, Fukuhori M, et al: Practical nitric oxide oasurement employing an NO-selective electrode. Rev. Sci. Instrum . 65(8) : 1-5, 1994.

• 2) Takemura S, Kawada N, Minamiyama Y, et al: Regulation of hepatic circulation by nucleotides, nitric oxide and endotoxin. In frontiers of reactive oxygen species in biology and medicine (edited by Asada K Yoshikawa T) , Excerpta Medica, dam, 1994, pp. 233-234.

• 3) Thurman RG, Marzi I, Seitz G, et Hepatic reperfusion injury following thotopic liver transplantation in the Transplantation 46: 502-506.

• 4) Starzl TE and Demetris AJ: Liver transplantation (edidted by Starzl TE and Demetris AJ) , Year Book Medical Publisher Inc., New York, 1990 pp. 43-130.

• 5) Demetris AJ, Kakizoe S, Oguma S: Pathology of liver transplantation. In Hepatic Transplantation(edited by Williams JW) , Sounders Company, New York, 1990, pp. 60-113.

• 6) Kawada N, Tran-Thi TA and Decker K: The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances possible involvement of endothelin-1 and nitric oxide in the regulation of sinusoidal tonus. Eur. J. Biochem. 213: 815-823, 1993.
  pubmed

• 7) Takemura S, Kawada N, Kinoshita H, et al: Nucleotide receptors in hepatic stellate cells of the rat. FEBS Lett. (in press) .

P.130 掲載の参考文献

• 1) Yoshimine T, Nakajima S, Hayakawa T, et al: rCBF versus microvascular plasma circulation in focal cerebral ischemia. J. Cereb. Blood. Flow. Metab. 9: S170, 1989.

• 2) Beckman JS: The double-edged role of nitric oxide in brain function and superoxide mediated injury. J. Dev. Physiol. 15: 53-59, 1991.
  pubmed

• 3) Malinski T, Bailey F, Zhallg ZG, et al: Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood. Flow. Metab. 14: 487-491, 1993.

• 4) Tamura A, Graham DI, McCulloch J, et al: Focal cerebral ischemia in the rat 1; Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood. Flow. Metab. 1: 53-60, 1981.
  pubmed

• 5) Green LC, Wagner DA, Glogowski J, et al: Analysis of nitrate, nitrite and[15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138, 1982.
  pubmed

• 6) Kosaka H, Watanabe M, Yoshihara H, et al: Detection of nitric oxide production in lipopolysaccharide-treated rats by ESR using carbon n, onoxide hemoglobin. Biochem. Biophys. Res. Commun. 184: 1119-1124, 1992.

• 7) Kosaka H, Imaizumi K and Tyuma I: Mechanism of autocatalytic oxidatioll of oxyhenioglobin by nitrite. An intermediate detected by electron spin resonance. Biochem. Biophys. Acta 702: 237-241, 1982.
  pubmed

• 8) Kumura E, Yoshimine T, Kato A, et al: The in situ chemiluminescence of ischemic rat brain. J. Cereb. Blood. Flow. Metab. 13: S36, 1993.

• 9) Koppenol WH, Moreno JJ, Pyror WA, et al: Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5: 834-842, 1992.

• 10) Raji R, Beckman JS, Bush KM, et al: Peroxynitrite induced membrane lipid peroxidation;the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288: 481-487, 1991.

P.133 掲載の参考文献

• 1) Barret RJ and Droppleman DA: Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II. Am. J. Physiol. 1265 (Renal Fluid Electolyte Physiol. 34) : F651-F659, 1993.

• 2) Sigmon DH and Beierwaltes WH: Angiotensin II;nitric oxide interaction and the distribution of blood flow. Am. J. Physiol 265(Regulatory Intergrative Comp. Physiol. 34) : R1276-R1283, 1993.

• 3) Owada A, Tomita K, Terada Y, Sakamoto H, et al: Endothelin(ET) -3 stimulates cyclic guanosine 3', 5'-monophog. phate production via ET, receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells. J. Clin. In vest. 93: 556-563, 1994.

• 4) Cattell V, Cook T and Moncada S: Glomeruli synthesize nitrite in experimental nephrotoxic nephritis. Kidney Int. 38: 1056-1060, 1990.
  pubmed

• 5) Cattell V Largen P, DeHeer E and Cook T: Glomeruli svnthesize nitrite in active Heymann nephritis;the source is infiltrating macrophages. Kindney Int. 40: 847-851, 1991.

• 6) Cook HT and Sullivan R: Glomerular nitrite synthesis in in situ immune complex glomerulonephritis in the rat. Am. J. Pathol. 139: 1047-1052, 1991.
  pubmed

• 7) Cattell V, Lianos E, Largen P and Cook T: Glomerular NO synthase activity in mesangial cell immune injury. Exp. Nephrol. 1: 36-40, 1993
  pubmed

• 8) Remuzzi G, Perico N, Zoja C, et al: Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. J. Clin. Invest. 86: 1768-1771, 1990.
  pubmed

• 9) Quintero E and Guth PH: Renal failure increases gastric mucosal blood flow and acid secretion in rat ; role of endothelium-derived nitic oxide. Am. J. Physiol. 263: G75-G80, 1992.

• 10) Conger JD, Robinette JB and Schvier RW: Smooth muscle calcium and endotheliumderived relaxing factor in the abnormal vascular responses of acute renal failure. J. Clin. Invest. 82: 532-537, 1988.

• 11) Vallance P, Leone A, Calver A, et al: Accumulation of an endogenous inhibitor of nitic oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992.

• 12) Noris M, Benigni A, Boccardo P, et al: Enhanced nitic oxide synthesis in uremia;Implications for platelet dysfunction and dialysis hypotension. Kidney Int. 44: 445-450, 1993.

• 13) Wennmalm A, Benthin G, Edlund A, J-mgersten L, et al: Metabolism and excretion of nitric oxide in humans;An experimental and clinical study. Circ. Res. 76: 1121: 1127, 1993.

P.137 掲載の参考文献

• 1) Nakazono K, Watallabe N, Matsuo K, et al: Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. U. S-A 88: IOO45-10048, 1991.

• 2) Fujita T, Nishikawa M, Tamaki C, et al: Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono-and poly-saccharide derivatives. J. Pharmacol. Exp. Ther. 263: 971-978, 1992.